BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1359806)

  • 21. Transamidating activities of factor XIIIa and of transglutaminases, measured by an ELISA procedure.
    Velasco PT; Karush F; Lorand L
    Biochem Biophys Res Commun; 1988 Apr; 152(2):505-11. PubMed ID: 2896499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A specific colorimetric assay for measuring transglutaminase 1 and factor XIII activities.
    Hitomi K; Kitamura M; Alea MP; Ceylan I; Thomas V; El Alaoui S
    Anal Biochem; 2009 Nov; 394(2):281-3. PubMed ID: 19646949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The comparative ability of plasma and tissue transglutaminases to use collagen as a substrate.
    Jeleńska MM; Fesüs L; Kopeć M
    Biochim Biophys Acta; 1980 Dec; 616(2):167-78. PubMed ID: 6111338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural features of glutamine substrates for transglutaminases. Role of extended interactions in the specificity of human plasma factor XIIIa and of the guinea pig liver enzyme.
    Gorman JJ; Folk JE
    J Biol Chem; 1984 Jul; 259(14):9007-10. PubMed ID: 6146608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro modification of betaine-homocysteine S-methyltransferase by tissue-type transglutaminase.
    Ichikawa A; Ohashi Y; Terada S; Natsuka S; Ikura K
    Int J Biochem Cell Biol; 2004 Oct; 36(10):1981-92. PubMed ID: 15203112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tridegin, a new peptidic inhibitor of factor XIIIa, from the blood-sucking leech Haementeria ghilianii.
    Finney S; Seale L; Sawyer RT; Wallis RB
    Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):797-805. PubMed ID: 9210403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of an isoenzyme-specific colorimetric assay for tissue transglutaminase 2 cross-linking activity.
    Perez Alea M; Kitamura M; Martin G; Thomas V; Hitomi K; El Alaoui S
    Anal Biochem; 2009 Jun; 389(2):150-6. PubMed ID: 19318081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microtiter assay for measurement of factor XIII activity in plasma.
    Dempfle CE; Harenberg J; Hochreuter K; Heene DL
    J Lab Clin Med; 1992 May; 119(5):522-8. PubMed ID: 1349910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous activity assay of two transglutaminase isozymes, blood coagulation factor XIII and transglutaminase 2, by use of fibrinogen arrays.
    Kwon MH; Jung SH; Kim YM; Ha KS
    Anal Chem; 2011 Nov; 83(22):8718-24. PubMed ID: 21961727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein (a) is a substrate for factor XIIIa and tissue transglutaminase.
    Borth W; Chang V; Bishop P; Harpel PC
    J Biol Chem; 1991 Sep; 266(27):18149-53. PubMed ID: 1680857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural features of glutamine substrates for transglutaminases. Specificities of human plasma factor XIIIa and the guinea pig liver enzyme toward synthetic peptides.
    Gorman JJ; Folk JE
    J Biol Chem; 1981 Mar; 256(6):2712-5. PubMed ID: 6110660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transglutaminase C in cerebellar granule neurons: regulation and localization of substrate cross-linking.
    Perry MJ; Mahoney SA; Haynes LW
    Neuroscience; 1995 Apr; 65(4):1063-76. PubMed ID: 7617162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A microtiter plate assay for factor XIII A-chain-fibrin interactions.
    Achyuthan KE; Santiago MA; Greenberg CS
    Anal Biochem; 1994 May; 219(1):43-8. PubMed ID: 8059954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteopontin, a substrate for transglutaminase and factor XIII activity.
    Prince CW; Dickie D; Krumdieck CL
    Biochem Biophys Res Commun; 1991 Jun; 177(3):1205-10. PubMed ID: 1676261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A nonradioactive dot blot assay for transglutaminase activity.
    McConoughey SJ; Niatsetskaya ZV; Pasternack R; Hils M; Ratan RR; Cooper AJ
    Anal Biochem; 2009 Jul; 390(1):91-3. PubMed ID: 19306836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-overexpression of folding modulators improves the solubility of the recombinant guinea pig liver transglutaminase expressed in Escherichia coli.
    Ikura K; Kokubu T; Natsuka S; Ichikawa A; Adachi M; Nishihara K; Yanagi H; Utsumi S
    Prep Biochem Biotechnol; 2002 May; 32(2):189-205. PubMed ID: 12071648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substrate specificities of microbial transglutaminase for primary amines.
    Ohtsuka T; Sawa A; Kawabata R; Nio N; Motoki M
    J Agric Food Chem; 2000 Dec; 48(12):6230-3. PubMed ID: 11141280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-throughput screening for transglutaminase activities using recombinant fluorescent proteins.
    Lee JH; Song E; Lee SG; Kim BG
    Biotechnol Bioeng; 2013 Nov; 110(11):2865-73. PubMed ID: 23740563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysine-rich histone (H1) is a lysyl substrate of tissue transglutaminase: possible involvement of transglutaminase in the formation of nuclear aggregates in (CAG)(n)/Q(n) expansion diseases.
    Cooper AJ; Wang J; Pasternack R; Fuchsbauer HL; Sheu RK; Blass JP
    Dev Neurosci; 2000; 22(5-6):404-17. PubMed ID: 11111157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transglutaminase activity of human ER-60.
    Okudo H; Kito M; Moriyama T; Ogawa T; Urade R
    Biosci Biotechnol Biochem; 2002 Jun; 66(6):1423-6. PubMed ID: 12162574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.